Vemurafenib for BRAF V600-mutant Erdheim-Chester disease and Langerhans cell histiocytosis: analysis of data from the histology-independent, phase 2, open-label VE-BASKET study - Diamond, EL; Subbiah, V; Lockhart, AC (JAMA, 2018)
et al.